Abbott Receives FDA Approval For Esprit BTK Drug-Eluting Resorbable Scaffold

 
• By Marion Webb
Abbott's Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit™ BTK System)
• Source: Abbott

More from Regulation

More from Policy & Regulation